Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

31.43
-6.8400-17.87%
Volume:266.20K
Turnover:8.54M
Market Cap:62.53M
PE:- -
High:35.79
Open:35.57
Low:30.50
Close:38.27
52wk High:391.58
52wk Low:12.38
Shares:1.99M
Float Shares:1.99M
Volume Ratio:0.95
T/O Rate:13.38%
Dividend:1.98
Dividend Rate:6.30%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Jun 02

Hims & Hers Health - Amendment Facilitates Closing of Eucalyptus Acquisition With Grace Period for Covenant Compliance - SEC Filing

THOMSON REUTERS
·
Jun 02

Hims & Hers Health - Enters Amendment No. 3 to Revolving Credit Agreement on May 29, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 02

Hims & Hers completes acquisition of Eucalyptus parent Juniper platform

Reuters
·
Jun 02

Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany

THOMSON REUTERS
·
Jun 02

Hims & Hers Completes Acquisition of Eucalyptus, Advancing Its Position as the World’s Largest Consumer Health Platform

THOMSON REUTERS
·
Jun 02

Hims & Hers Health - Expands Benefits Program With Eight New Partners

THOMSON REUTERS
·
May 29

BUZZ-U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 Bio

Reuters
·
May 27

BUZZ-U.S. STOCKS ON THE MOVE-MGM, Hims & Hers, Semtech

Reuters
·
May 27

BUZZ-Hims & Hers rises as board member boosts stake amid stock rout

Reuters
·
May 27

Hims & Hers Health Shares up 2.2% Premarket; Board Member David Wells Buys Nearly $1.2 Mln in Stock

THOMSON REUTERS
·
May 27

Can Hims & Hers (HIMS) Canadian GLP-1 Push Redefine Its Long-Term Profitability Playbook?

Simply Wall St.
·
May 27

Hims & Hers director David B. Wells reports purchase of 48,400 shares for $1.17 million

Reuters
·
May 27

Hims & Hers Health Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 27

Moderately bullish activity in Hims and Hers Health with shares down 0.32%

TIPRANKS
·
May 27

BUZZ-BofA says Hims & Hers 2026 revenue target hinges on GLP-1 growth, lowers PT

Reuters
·
May 26

Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 26

BofA Adjusts Price Target on Hims & Hers Health to $25 From $28

MT Newswires Live
·
May 26

Hims & Hers : Bofa Global Research Cuts Price Objective to $25.00 From $28.00

THOMSON REUTERS
·
May 26

Does Medicine's New Obsession Really Work? -- Barron's

Dow Jones
·
May 23